Skip to main content
. 2020 Oct 31;21(21):8185. doi: 10.3390/ijms21218185

Table 1.

Fatalities after α-PVP application published in medical literature.

Country
Year
Number
Intoxicated/Death
α-PVP in Blood Other Drugs Found in the Blood Remarks Information Reference
Finland 2012 1/1 70 ng/mL doxepine, citalopram, quetiapine, buprenorphine temazepam. suicide [65]
Finland 2014 1/1 60 ng/mL amphetamine, ketamine. [65]
United States 2013 3/3 10 ng/mL
29 ng/mL
52 ng/mL
pentedrone
sertraline,
7-amino-lonazepam, oxycodone, THC.
deaths of three men aged 31, 35, and 51 years. [66]
United States 2013 6/6 only qualitative estimation morphine,
codeine,
hydrocodone,
6-monoacetylmorphine
deaths of four women between 32 and 44 years, and two men aged 34 and 51 years. [29]
United States 2012-2015 21/3 50-90 ng/mL clonazepam, diazepam, oxycodone, THC, alprazolam, oxazepam, tamazepam. [72]
Japan 2013 1/1 486 ng/mL no other drugs. [67]
Japan 2014 2/2 411 ng/mL
579 ng/mL
no other drugs. [58,68]
Australia 2014 1/1 only qualitative estimation no other drugs. cardiac arrest [73]
Poland 2015 1/1 185 ng/ml pentedrone. [74]
Poland 2016 1/1 174 ng/ml no other drugs. technique revealed the presence of α-PVP in the following concentrations: urine, 401 ng/mL; brain, 292 ng/g; liver, 190 ng/g; kidney, 122 ng/g; gastric content, 606 ng/g. cardiac arrest secondary to intoxication with alpha-PVP was determined as the direct cause of the patient’s death. [75]
Finland 2020 1/1 800 ng/ml amphetamine, buprenorphine, benzodiazepines. sudden death of a middle-aged man while having a sauna. [76]